touchPODCAST

By touchpodcast

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.

Educating physicians on a fully global... more

· Science

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about touchPODCAST:

How many episodes does touchPODCAST have?

The podcast currently has 542 episodes available.

touchPODCAST episodes:

July 29, 2025Focus on treatment advances for ATTRv: A heterogeneous, highly debilitating and ultimately fatal disease
touchEXPERT FOCUS for touchNEUROLOGY and touchCARDIO
Listen to Dr Chafic Karam share expert insights on diagnosing and managing ATTRv amyloidosis. In this short interview, he covers red-flag symptoms, diagnostic challenges and key strategies for differentiating ATTRv. He also discusses current treatment options, including TTR stabilisers and gene silencers, as well as emerging therapies aimed at improving patient outcomes.
The expert:
Dr Chafic Karam, University of Pennsylvania, Philadelphia, PA, USA
This touchPODCAST is for HCPs in the USA only.
This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME.
For further information visit our websites:
https://touchneurology.com/ and https://touchcardio.com/
...more
20min
July 09, 2025Navigating the treatment of RRMM with BCMA-directed therapies: Updates from COMy, ASCO and EHA 2025
touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY
Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy), American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) 2025 congresses. Prof. Moreau is then joined by fellow experts Dr Paola Neri and Prof. Hermann Einsele to discuss how these data may apply in clinical practice.
Overview
Data reviews with Prof. Moreau
Expert panel discussions with Prof. Moreau, Dr Neri and Prof. Einsele on the themes below
Clinical themes
Approved BCMA-directed therapeutic approaches
Practical application of BCMA-directed therapies
Future of treating RRMM: Emerging BCMA-directed therapies and combinations
The internationally renowned multiple myeloma expert faculty
Prof. Philippe Moreau: Nantes, France
Prof. Hermann Einsele: Würzburg, Germany
Dr Paola Neri: Calgary, AB, Canada
This touchPODCAST is for HCPs outside of the USA.
This activity is funded by an independent medical education grant from GSK.
This activity is provided by touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com
...more
1h 10min
July 07, 2025Advancing care for patients with infantile haemangiomas: Timing is key
touchEXPERT FOCUS for touchDERMATOLOGY

Listen to Prof. Ilona Frieden share expert insights on the clinical management of infantile haemangiomas, with a focus on timely referral and effective risk stratification. She also explores current and emerging treatment options and practical strategies to support families throughout a patient’s care journey.
The expert:
Prof. Ilona Frieden, University of California, San Francisco, CA, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Pierre Fabre Pharmaceuticals, Inc.

This activity is jointly provided by USF Health and touchIME in collaboration with our education partner, Pediatric Dermatology Research Alliance (PeDRA).

For further information visit our website:
https://touchdermaime.org/
...more
18min
June 26, 2025Incorporating ADCs into the treatment of mBC: Practical considerations for the community oncologist
touchIN CONVERSATION for touchONCOLOGY
Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC-associated toxicities.
The experts
Prof. Giuseppe Curigliano, European Institute of Oncology and University of Milan, Italy
Dr Alison Conlin, Providence Cancer Institute, Portland, OR, USA
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Gilead Sciences, Inc.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information, visit our website: https://touchoncologyime.org/adcs-in-the-treatment-of-mbc/
...more
36min
June 25, 2025Multidisciplinary management of TNBC Integrating immunotherapies for early and metastatic disease
touchEXPERT FOCUS for touchONCOLOGY
Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits.
The experts:
Prof. Sherko Kümmel – Kliniken Essen-Mitte, Essen, Germany
Prof. Rebecca Dent – National Cancer Center Singapore, Singapore
Prof. Peter Schmid – Barts Cancer Institute, London, UK
This touchPODCAST is for healthcare professionals outside of the UK.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
https://touchoncologyime.org/management-of-tnbc-with-immunotherapy/
...more
37min
June 23, 2025Applying immunotherapy in clinical practice for patients with early-stage NSCLC
touchEXPERT FOCUS for touchRESPIRATORY
Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.
The expert
Prof. Jonathan Spicer, McGill University, Montreal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information, visit our website: https://touchrespiratoryime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/
...more
17min
June 23, 2025Applying immunotherapy in clinical practice for patients with early-stage NSCLC
touchEXPERT FOCUS for touchONCOLOGY
Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation.
The expert
Prof. Jonathan Spicer, McGill University, Montreal, Canada
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.
The activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.

For further information, visit our website: https://touchoncologyime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/
...more
17min
June 19, 2025Towards personalized care for people living with HIV: Supporting open dialogue and informed treatment choices
NEW touchCASES for touchINFECTIOUS DISEASES
Listen to Prof. José Arribas, a leading HIV expert, and Ms Harriet Langanke, a journalist and HIV activist, discuss personalized care strategies for people living with HIV, focusing on three key concerns: weight gain, pill fatigue and treatment initiation.
The experts:
Prof. José Arribas, University Hospital La Paz, Madrid, Spain,
Ms Harriet Langanke, GSSG, Cologne, Germany
This touchPODCAST is for HCPs outside of the UK
This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information, visit our website: https://touchinfectiousdiseases.com
...more
35min
June 11, 2025Accelerating myasthenia gravis diagnosis and treatment: Practical strategies and therapeutic advances
touchIN CONVERSATION for touchNEUROLOGY
Listen as two experts discuss the practical considerations for the diagnosis of myasthenia gravis (MG), serological subgroup testing and the implementation of newly available treatments for MG. They will also consider the emerging treatments for generalized MG and the potential impact on the therapeutic landscape.
The experts
Dr Carolina Barnett-Tapia, University of Toronto, Toronto, ON, Canada
Prof. Nils Erik Gilhus, University of Bergen and Haukeland University Hospital, Bergen, Norway
This touchPODCAST is for HCPs outside of the UK.
This activity is funded by an independent medical education grant from Healthcare
Business of Merck KGaA, Darmstadt, Germany.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: www.touchneurology.com
...more
40min
May 15, 2025RET-positive NSCLC: Translating insights into targeted approaches
touchFOCUS for touchRESPIRATORY
In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC.
The expert:
Dr Christine Bestvina - University of Chicago, Chicago, IL, USA
This touchPODCAST is for HCPs outside the UK.

This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc.

This activity is jointly provided by USF Health and touchIME.

For further information visit our website: touchrespiratory.com
...more
15min

FAQs about touchPODCAST:

How many episodes does touchPODCAST have?

The podcast currently has 542 episodes available.